Posts Tagged Market

Research And Development Of Pharmaceutical Industry Market

Pharmaceutical Industry Market Review Report ( http://www.bharatbook.com/Market-Research-Reports/Pharmaceutical-Industry-Market-Review.html ) which gives the information about the growth of Pharmaceutical Industry Market.  The total UK market for pharmaceuticals was worth an estimated £13.65bn in 2007. Prescription-only medicines accounted for most of this figure, with a smaller share being taken by over-the-counter (OTC) pharmaceuticals.  The UK is home to the most [...]

No Comments

Bharatbook.com : Pharmaceutical Market Access and Drug Safety Act of 2009

Prospects for Legalizing Drug (Re-)Importation to the United States report ( http://www.bharatbook.com/Market-Research-Reports/Prospects-for-Legalizing-Drug-Re-Importation-to-the-United-States.html ) provides the information about the Rise, Fall and Partial Recovery of International Pharmacies. President Barack Obama said during his election campaign he would ‘allow Americans to buy their medicines from other developed countries if the drugs are safe and prices are lower [...]

No Comments

Home Drug Test Market Sees OxyContin Test Fill A Vital Niche for Parents

The Problem of Prescription Oxycodone AbuseAs you may know, prescription drug abuse has developed into a huge problem in the United States. For example, a 2005 Monitoring the Future survey of high school students showed that OxyContin abuse went up among 12th graders by 40 percent in 3 years. OxyContin is one of the many [...]

No Comments

GAO Chun-fang: Drug factory price market pricing should be transparent – Healthcare Reform – the pharmaceutical industries

“Medical reform, prevention is more important than treatment, I suggest that 1.3 billion Chinese people to establish health disease patterns, preventive measures!” Yesterday, the Third Session of the CPPCC National Committee first held a press conference, GAO Chun-fang, WU Ling, Co Dong Liang, Ai-Ping Lü, Wen Jianmin CPPCC members and other five medical reform in [...]

No Comments

Vision Shopsters: The South Korean Pharmaceutical Market Outlook to 2014: Healthcare regulation and reforms, disease burden and market dynamics

South Korea has moved from being a developing pharmaceutical market to a fully fledged developed market in the past ten years. The Ministry of Health and Welfare is the nodal agency for protecting public health in South Korea. The country’s public health status has improved with respect to infant mortality and life expectancy. This has [...]

No Comments

Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth

The pharmaceutical industry is challenged with information integration and mapping across the various business processes. This information challenge, along with other issues such as weak product development pipelines, growing generics competition, and rising R&D and regulatory compliance costs are compelling pharmaceutical companies to look for alternatives to remain competitive, maintain profit margins, and enhance market [...]

No Comments

China Pharmaceutical Industry: Analysis And Market Trends

The domestic pharmaceutical market is highly fragmented and inefficient. China, as of 2007, has around 3,000 to 6,000 domestic pharmaceutical manufacturers and around 14,000 domestic pharmaceutical distributors. Most often cited adverse factors include a lack of protection of intellectual property rights, a lack of visibility for drug approval procedures, a lack of effective governmental incentives, [...]

No Comments

The Russian Pharmaceutical Market Outlook to 2014: Policy environment, market structure, competitive landscape, growth opportunities

Russia’s well educated and low cost workforce is one of the main attraction for investors all over the world. According to recent statistics, Russia’s population (which is currently about 141m) is steadily declining at a rate of around 0.4%. Thus, the government is trying to remedy this through several immigration policies and federal programs such [...]

No Comments

Italy Pharmaceutical Market Overview Generic penetration set to rise now available at ReportsandReports

The prescription pharmaceutical market in Italy was valued at .9 billion in 2009. Key growth drivers for branded pharma include the growing use of chronic high-value innovative treatments driven by a growing elderly population, the high proportion of the healthcare budget spent on pharmaceuticals, and a high level of brand loyalty among Italian patients. Scope [...]

No Comments

Australia Pharmaceutical Market Overview – Reforms and continued price cuts will change the healthcare landscape now available at ReportsandReports

The prescription pharmaceutical market in Australia was valued at .1 billion in 2009. Key growth drivers include the growing use of chronic high-value innovative treatments driven by a rising elderly population and high public spending as a proportion of total healthcare expenditure. Scope * Overview of Australia’s socioeconomics and demographics, healthcare system, regulation, pricing and [...]

No Comments